Acute Coronary Syndrome Treatment Costs from the Perspective of the Supplementary Health System
- PMID: 26559980
- PMCID: PMC4632997
- DOI: 10.5935/abc.20150129
Acute Coronary Syndrome Treatment Costs from the Perspective of the Supplementary Health System
Abstract
Background: Acute coronary syndrome (ACS) is defined as a "group of clinical symptoms compatible with acute myocardial ischemia", representing the leading cause of death worldwide, with a high clinical and financial impact. In this sense, the development of economic studies assessing the costs related to the treatment of ACS should be considered.
Objective: To evaluate costs and length of hospital stay between groups of patients treated for ACS undergoing angioplasty with or without stent implantation (stent+ / stent-), coronary artery bypass surgery (CABG) and treated only clinically (Clinical) from the perspective of the Brazilian Supplementary Health System (SHS).
Methods: A retrospective analysis of medical claims of beneficiaries of health plans was performed considering hospitalization costs and length of hospital stay for management of patients undergoing different types of treatment for ACS, between Jan/2010 and Jun/2012.
Results: The average costs per patient were R$ 18,261.77, R$ 30,611.07, R$ 37,454.94 and R$ 40,883.37 in the following groups: Clinical, stent-, stent+ and CABG, respectively. The average costs per day of hospitalization were R$ 1,987.03, R$ 4,024.72, R$ 6,033.40 and R$ 2,663.82, respectively. The average results for length of stay were 9.19 days, 7.61 days, 6.19 days and 15.20 days in these same groups. The differences were significant between all groups except Clinical and stent- and between stent + and CABG groups for cost analysis.
Conclusion: Hospitalization costs of SCA are high in the Brazilian SHS, being significantly higher when interventional procedures are required.
Conflict of interest statement
Drs. Tony Piha and Paulo Miranda are employees of AstraZeneca Brazil. Vanessa Teich, Lucas Fahham, Haline Bianca Squiassi are employees of Medinsight, company that received funding from AstraZeneca to perform the analysis and preparation of the article.
Figures
References
-
- Polanczyk CA, Ribeiro JP. Coronary artery disease in Brazil: contemporary management and future perspectives. Heart. 2009;95(11):870–876. - PubMed
-
- Souza e Silva NA. Saúde cardiovascular na era tecnológica. Arq Bras Cardiol. 2004;83(6):453–455. - PubMed
-
- Ministério da Saúde . Protocolo Clínico Síndromes Coronarianas Agudas. Brasília: 2011. [2013]. Disponível em: http://portal.saude.gov.br/portal/arquivos/pdf/protocolo_clinico_sindrom....
-
- Polanczyk CA, Prado K, Borges MS, Ribeiro JP. Acute myocardial infarction in the thrombolytic era: high mortality in elderly patients. Rev Assoc Med Bras. 1993;39(2):65–72. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
